X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Lupin Ltd with Cadila Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs CADILA HEALTHCARE - Comparison Results

LUPIN    Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

CADILA HEALTHCARE 
   Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN CADILA HEALTHCARE LUPIN/
CADILA HEALTHCARE
 
P/E (TTM) x 41.0 12.9 318.1% View Chart
P/BV x 2.5 2.7 92.9% View Chart
Dividend Yield % 0.7 1.5 43.6%  

Financials

 LUPIN   CADILA HEALTHCARE
EQUITY SHARE DATA
    LUPIN
Mar-18
CADILA HEALTHCARE
Mar-18
LUPIN/
CADILA HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs1,465558 262.5%   
Low Rs727362 201.1%   
Sales per share (Unadj.) Rs349.6116.3 300.6%  
Earnings per share (Unadj.) Rs5.617.9 31.1%  
Cash flow per share (Unadj.) Rs29.623.1 127.9%  
Dividends per share (Unadj.) Rs5.003.50 142.9%  
Dividend yield (eoy) %0.50.8 59.9%  
Book value per share (Unadj.) Rs300.385.4 351.6%  
Shares outstanding (eoy) m452.081,023.74 44.2%   
Bonus/Rights/Conversions ESOPS--  
Price / Sales ratio x3.14.0 79.3%   
Avg P/E ratio x197.225.7 766.4%  
P/CF ratio (eoy) x37.119.9 186.4%  
Price / Book Value ratio x3.65.4 67.8%  
Dividend payout %90.019.6 459.3%   
Avg Mkt Cap Rs m495,502470,664 105.3%   
No. of employees `00017.011.8 144.2%   
Total wages/salary Rs m28,64718,545 154.5%   
Avg. sales/employee Rs Th9,273.610,072.7 92.1%   
Avg. wages/employee Rs Th1,681.01,569.1 107.1%   
Avg. net profit/employee Rs Th147.41,547.7 9.5%   
INCOME DATA
Net Sales Rs m158,042119,049 132.8%  
Other income Rs m1,5041,132 132.8%   
Total revenues Rs m159,545120,181 132.8%   
Gross profit Rs m31,47528,475 110.5%  
Depreciation Rs m10,8595,388 201.5%   
Interest Rs m2,044911 224.3%   
Profit before tax Rs m20,07623,308 86.1%   
Minority Interest Rs m-71628 -11.3%   
Prior Period Items Rs m350-   
Extraordinary Inc (Exp) Rs m-14,6440-   
Tax Rs m2,8855,644 51.1%   
Profit after tax Rs m2,51318,292 13.7%  
Gross profit margin %19.923.9 83.3%  
Effective tax rate %14.424.2 59.3%   
Net profit margin %1.615.4 10.3%  
BALANCE SHEET DATA
Current assets Rs m122,09582,005 148.9%   
Current liabilities Rs m50,95660,720 83.9%   
Net working cap to sales %45.017.9 251.8%  
Current ratio x2.41.4 177.4%  
Inventory Days Days8573 115.7%  
Debtors Days Days12098 122.0%  
Net fixed assets Rs m129,87683,703 155.2%   
Share capital Rs m9041,024 88.3%   
"Free" reserves Rs m134,86686,421 156.1%   
Net worth Rs m135,77187,445 155.3%   
Long term debt Rs m64,24525,551 251.4%   
Total assets Rs m263,054180,653 145.6%  
Interest coverage x10.826.6 40.7%   
Debt to equity ratio x0.50.3 161.9%  
Sales to assets ratio x0.60.7 91.2%   
Return on assets %1.710.6 16.3%  
Return on equity %1.920.9 8.8%  
Return on capital %3.722.0 16.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m53,14142,683 124.5%   
Fx outflow Rs m19,33511,242 172.0%   
Net fx Rs m33,80731,441 107.5%   
CASH FLOW
From Operations Rs m17,5129,193 190.5%  
From Investments Rs m-14,073-9,737 144.5%  
From Financial Activity Rs m-14,921515 -2,897.3%  
Net Cashflow Rs m-11,482-29 39,592.1%  

Share Holding

Indian Promoters % 46.6 74.8 62.3%  
Foreign collaborators % 0.2 0.0 -  
Indian inst/Mut Fund % 11.3 8.3 136.1%  
FIIs % 31.9 5.9 540.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.1 11.0 91.8%  
Shareholders   98,259 44,069 223.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN With:   SUN PHARMA  MERCK  NOVARTIS  FULFORD INDIA  DR. REDDYS LAB  

Compare LUPIN With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End Higher, IPO Buzz, and Top Cues in Focus Today(Pre-Open)

On Tuesday, Indian share markets witnessed most of the buying interest during closing hours and ended their trading session on a strong note.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 21.0% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 21.0% YoY). Sales on the other hand came in at Rs 37 bn (up 14.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

LUPIN Announces Quarterly Results (4QFY19); Net Profit Down 1.5% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, LUPIN has posted a net profit of Rs 3 bn (down 1.5% YoY). Sales on the other hand came in at Rs 44 bn (up 77.8% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN LTD Announces Quarterly Results (3QFY19); Net Profit Down 149.7% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, LUPIN LTD has posted a net profit of Rs 2 bn (down 149.7% YoY). Sales on the other hand came in at Rs 45 bn (up 78.0% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 3.7% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 3.7% YoY). Sales on the other hand came in at Rs 36 bn (up 9.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

LUPIN LTD Announces Quarterly Results (2QFY19); Net Profit Down 31.1% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, LUPIN LTD has posted a net profit of Rs 3 bn (down 31.1% YoY). Sales on the other hand came in at Rs 40 bn (up 53.1% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

More Views on News

Most Popular

7 Stocks That Will Remain Evergreen in this Era of Technological Disruption(The 5 Minute Wrapup)

Jun 13, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

Why I Believe Smallcaps Will Catch up to the Sensex(Profit Hunter)

Jun 14, 2019

Smallcaps have gone nowhere even as the Sensex makes new all-time highs. Find out why Richa believes this a good opportunity to invest in smallcaps.

Why Super Investor Kenneth Andrade is Bullish on Agri Stocks...and So Are We(The 5 Minute Wrapup)

Jun 21, 2019

Andrade gives his take on agriculture, an industry from which we have already recommended two stocks.

This Little-Known Opportunity Promises Both Health and Wealth for Your Grandchildren(Profit Hunter)

Jun 20, 2019

The next big opportunity that has the potential to make you both rich and healthy.

My Upcoming Stock Recommendation, Backed by Aberdeen Standard Investments, Scores 9.1/10(The 5 Minute Wrapup)

Jun 19, 2019

This month's Smart Money Secrets recommendation is from global super investor - Aberdeen Standard Investments.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN SHARE PRICE


Jun 26, 2019 09:29 AM

TRACK LUPIN

COMPARE LUPIN WITH

MARKET STATS